In his 2015 State of the Union Address, President Obama introduced precision medicine as a priority initiative. The mission of the White House Precision Medicine Initiative is: To enable a new era of medicine through research, technology, and policies that empower patients, researchers, and providers to work together toward development of individualized treatments. In addition to research and clinical interventions that focus on precision medical treatment, IU’s Precision Health Initiative supplements such treatment-focused efforts with research that focuses on health, disease and risk behaviors as the products of bio-psycho-social processes that must be understood to foster human health. In addition to biomedical, translational and clinical research, IU’s Precision Health Initiative incorporates the social sciences, ethics, education, and data and computational sciences to enable us to better prevent, identify, and treat diseases across the life-span.

Developed by a team led by principal investigator Anantha Shekhar, M.D., Ph.D., IU’s Associate Vice President for University Clinical Affairs and IU School of Medicine’s executive associate dean for research affairs, the Precision Health Initiative is a $120 million investment in transforming biomedical research, health care, and Indiana University. As many as 39 new, full-time faculty members will be hired through the Initiative, at the IU School of Medicine, IU Bloomington, and IUPUI. New facilities will include new gene editing and sequencing cores at IUSM, a cell Good Manufacturing Practice facilities, and a cross-campus Center for Chemical Biology and Biotherapeutics. The program will also support the creation of a Precision Health Data Commons, a Precision Health Integration and Analytics Platform, a longitudinal precision health cohort, and new educational programs focusing on precision health.